Post argues a 10% holder increasing stake in a low-float microcap tightens float and could amplify moves into upcoming biotech catalysts.
MYNZ — WATCH The author argues a 10% holder adding 643,850 shares in a low-liquidity microcap tightens effective float, which can make moves sharper both up and down when news hits. He identifies upcoming catalysts: AACR pancreatic verification in April, CRC feasibility guided to H1 2026, and Europe scaling through UK/Switzerland/DoctorBox. He plans to size up gradually if supply looks thin and the company prints real operating data, while managing downside risk.
If supply looks thin and the company prints real operating data, I size up gradually.
This Reddit post, published January 20, 2026, features u/SockDiplomat discussing MYNZ. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/SockDiplomat · Tickers: MYNZ